Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Editas Medicine

Recent news which mentions Editas Medicine

The Past Week's Most Notable Insider Buys: Editas, Exxon Mobil, Wayfare And More
Tickers ADC ATEC CLF CLI
Tags LendingTree DISCA Alphatec
From Benzinga
Barron's Picks And Pans: Exxon Mobil, GameStop, Intel, 3M, Toll Brothers And More
Tickers AMZN CRSP CVX DIS
Tags gamestop Intel Trading Ideas
From Benzinga
Pioneering CRISPR researcher Jennifer Doudna is coming to Disrupt
Tickers TC
Tags Biotech Intellia Therapeutics Disrupt 2020
From TechCrunch
CRISPR Therapeutics stock jumps on early gene editing data
Tags bluebird bio Inc/ (Cambridge MA) Acceleron Pharma Editas Medicine
From Business Journals
After $59M round, CRISPR startup launches with plans to tackle heart disease
Tags Sekar Kathiresan Biotech Venture capital
From Business Journals
Editas, BlueRock combine forces on gene and cell therapy
Tags Insurance Pharmaceuticals Biotech
From Business Journals
Barron's On: Pharma's Big Hope
Tickers CRSP EDIT NVS PFE
Tags NVS Editas Medicine General
From Benzinga
Barron's Picks And Pans: Conagra, JPMorgan, L Brands, Weight Watchers And More
Tickers ABBV CAG CRSP EDIT
Tags ABBV AbbVie Editas Medicine
From Benzinga
Allergan joins biotech swarm in Kendall Square with R&D hub
Tags Aerospace David Nicholson Biotech
From Business Journals
Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies
Tickers TC
Tags Editas Medicine johnson & johnson executive
From TechCrunch
FDA clears testing for another gene-editing drug in humans
Tags Health Care Allergan Vertex Pharmaceuticals
From Business Journals
FDA clears Editas to test gene-editing drug in humans
Tags Health Care Editas Medicine Vertex Pharmaceuticals
From Business Journals
Cambridge's Editas asks FDA to start gene editing trial
Tags Editas Medicine, Inc/ Duke University Bioscience
From Business Journals
Broad Institute wins landmark case over gene editing patents
Tags Health Care Emmanuelle Charpentier Editas Medicine
From Business Journals
CRISPR, Vertex launch first company-backed gene editing trial in humans
Tags CRISPR Therapeutics AG Health Care Vertex Pharmaceuticals Incorporated
From Business Journals
These Mass. biotechs put their money where their labs are
Tags Colleges & Universities Editas Medicine Sanofi
From Business Journals
Exclusive: Gene editing pioneer Feng Zhang launches new startup in Cambridge
Tags Editas Medicine CRISPR Therapeutics AG Health Care
From Business Journals
FDA warns against ‘do it yourself’ gene therapy kits
Tags Editas Medicine Health Care CRISPR Therapeutics AG
From Business Journals
MIT scientists deploy new CRISPR delivery system to edit genes in mice
Tickers MIT
Tags Editas Medicine Intellia Therapeutics, Inc/ MIT
From Business Journals
Editas CEO to testify at U.S. Senate hearing on gene editing potential, ethics
Tags Biotech Johns Hopkins University Johns Hopkins
From Business Journals
Gene editing startup Homology nabs $84M as Fidelity pitches in
Tickers AAV
Tags Editas Medicine, Inc/ Intellia Therapeutics Biotech
From Business Journals
Oral arguments for who owns CRISPR-Cas9 starts next month
Tickers BIO
Tags Editas Medicine CRISPR enzymes
From TechCrunch
CRISPR loses Nobel to tiny machines
Tickers BIO MIT TC
Tags emmanuelle charpentier feng zhang CRISPR
From TechCrunch
CRISPR will have to wait for that Nobel prize
Tickers TC
Tags TC Nobel prize CRISPR
From TechCrunch
Reshaping human health and changing lives through gene editing
Tickers TC
Tags agriculture talen Science
From TechCrunch
?Recent biotech IPOs get fewer new investors than it appears, says report
Tags Syndax Pharmaceuticals Biotech Technology
From Business Journals
Editas biotech stock drops by 26% over CRISPR patent dispute
Tickers BIO TC
Tags Bill Gates TC Health
From TechCrunch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.